GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mono Pharmacare Ltd (NSE:MONOPHARMA) » Definitions » 5-Year EBITDA Growth Rate

Mono Pharmacare (NSE:MONOPHARMA) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Mono Pharmacare 5-Year EBITDA Growth Rate?

Mono Pharmacare's EBITDA per Share for the six months ended in Mar. 2025 was ₹2.17.

During the past 12 months, Mono Pharmacare's average EBITDA Per Share Growth Rate was 17.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 87.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mono Pharmacare was 98.10% per year. The lowest was 87.20% per year. And the median was 92.65% per year.


Competitive Comparison of Mono Pharmacare's 5-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mono Pharmacare's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's 5-Year EBITDA Growth Rate falls into.


;
;

Mono Pharmacare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Mono Pharmacare  (NSE:MONOPHARMA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Mono Pharmacare 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mono Pharmacare's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mono Pharmacare Business Description

Traded in Other Exchanges
N/A
Address
1A, Krinkal Apartment, Opp. Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd is a distributor and supplier of a wide array of Pharmaceuticals products and medicines. The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac-Diabetic medicines, and cosmocare products.

Mono Pharmacare Headlines

No Headlines